| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/16/2013 | US20130123479 Soluble TNF Receptors and Their Use in Treatment of Disease |
| 05/16/2013 | US20130123347 Fractalkine binding polynucleotides and methods of use |
| 05/16/2013 | US20130123346 Synthetic constructs for polynucleotide & protein expression |
| 05/16/2013 | US20130123337 RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma |
| 05/16/2013 | US20130123333 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications |
| 05/16/2013 | US20130123332 Compositions and methods for inhibiting expression of mylip/idol gene |
| 05/16/2013 | US20130123331 Modulation of diacylglycerol acyltransferase 2 expression |
| 05/16/2013 | US20130123329 Microrna compositions and methods |
| 05/16/2013 | US20130123327 Combined use of prame inhibitors and hdac inhibitors |
| 05/16/2013 | US20130123200 Mammalian cell surface antigens; related reagents |
| 05/16/2013 | US20130123146 Method of making a microbead array with attached biomolecules |
| 05/16/2013 | US20130123142 Composition for preventing or treating diabetes comprising nad glycohydrolase inhibitor as active ingredient |
| 05/16/2013 | US20130122591 Methods and compositions for modification of the hprt locus |
| 05/16/2013 | US20130122585 Synthetic gagpol genes and their uses |
| 05/16/2013 | US20130122582 Expression vector |
| 05/16/2013 | US20130122581 Tal effector-mediated dna modification |
| 05/16/2013 | US20130122573 Live Vaccine Strain |
| 05/16/2013 | US20130122572 Methods, compositions and kits for one-step dna cloning using dna topoisomerase |
| 05/16/2013 | US20130122569 Expression of Granular Starch Hydrolyzing Enzymes in Trichoderma and Process for Producing Glucose from Granular Starch Sustrates |
| 05/16/2013 | US20130122562 Production of isoprene, isoprenoid precursors, and isoprenoids using acetoacetyl-coa synthase |
| 05/16/2013 | US20130122553 Metabolically engineered organisms for the production of added value bio-products |
| 05/16/2013 | US20130122550 Multi-site mutagenesis |
| 05/16/2013 | US20130122548 Eubacterial RNA-Polymerase Mutants With Altered Product Production |
| 05/16/2013 | US20130122547 Yeast host, transformant and method for producing heterologous proteins |
| 05/16/2013 | US20130122545 Polypeptides Having Protease Activity and Polynucleotides Encoding Same |
| 05/16/2013 | US20130122544 Enzyme that catalyzes a peptide-forming reaction from a carboxy component and an amine component, microbe producing the same, and a method of producing a dipeptide using the enzyme or microbe |
| 05/16/2013 | US20130122501 Methods and vectors for producing transgenic plants |
| 05/16/2013 | US20130122105 Methods and Compositions for Gene Therapy and GHRH Therapy |
| 05/16/2013 | US20130122082 Methods And Compositions For The Treatment And Prevention Of Aging-Associated Conditions |
| 05/16/2013 | US20130122047 Streptococcus pyogenes antigens |
| 05/16/2013 | US20130122030 S. epidermidis antigens |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | US20130121995 Compositions and Methods for Increasing Bone Mineralization |
| 05/16/2013 | US20130121988 Nucleic Acid of Formula (I): GlXmGn, or (II): ClXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant |
| 05/16/2013 | US20130121966 Generation of PSA-only producing mutant strain |
| 05/16/2013 | US20130121960 Constitutive expression of costimulatory ligands on adoptively transferred t lymphocytes |
| 05/16/2013 | DE69132920C5 Methode zur Herstellung von filamentösen, antikörper-präsentierenden Bakteriophagenpartikeln durch Verwendung von Phagemiden und die daduch hergestellten Bakteriophagenpartikel Method for the production of filamentous bacteriophage particles by antibody-presenting use of phagemids and the bacteriophage produced Daduchus |
| 05/16/2013 | DE4321904B4 Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen A process for chromatographic purification and separation of Nucleinsäuregemischen |
| 05/16/2013 | CA2855368A1 Biomarkers of response to proteasome inhibitors |
| 05/16/2013 | CA2855362A1 Compounds for the modulation of beta-catenin expression and uses thereof |
| 05/16/2013 | CA2855358A1 Cyclin a1-targeted t-cell immunotherapy for cancer |
| 05/16/2013 | CA2855241A1 Compounds for the modulation of smn2 splicing |
| 05/16/2013 | CA2855124A1 A genetically modified strain of s. cerevisiae engineered to ferment xylose and arabinose |
| 05/16/2013 | CA2854817A1 Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
| 05/16/2013 | CA2854806A1 Multispecific and multivalent binding proteins and uses thereof |
| 05/16/2013 | CA2853679A1 Production of acetyl-coenzyme a derived isoprenoids |
| 05/16/2013 | CA2808850A1 High yielding soybean variety xb22t13 |
| 05/16/2013 | CA2808847A1 High yielding soybean variety xb06t13 |
| 05/16/2013 | CA2808846A1 High yielding soybean variety xb22z13 |
| 05/16/2013 | CA2808844A1 High yielding soybean variety xb32ak13 |
| 05/16/2013 | CA2808839A1 High yielding soybean variety xb32m13 |
| 05/16/2013 | CA2808832A1 High yielding soybean variety xb009m13 |
| 05/16/2013 | CA2808816A1 High yielding soybean variety xb03n13 |
| 05/16/2013 | CA2808806A1 High yielding soybean variety xb05a13 |
| 05/16/2013 | CA2808789A1 High yielding soybean variety xb31r13 |
| 05/15/2013 | EP2592149A1 Improved method for homologous recombination |
| 05/15/2013 | EP2592148A1 Protein expression from multiple nucleic acids |
| 05/15/2013 | EP2592147A1 Protein expression from multiple nucleic acids |
| 05/15/2013 | EP2592146A2 Methods and compositions for treating prostate cancer |
| 05/15/2013 | EP2592145A1 Medicament for the treatment of cardiac disease |
| 05/15/2013 | EP2592144A1 RNAI-mediated inhibition of Rho kinase 2 for treatment of ocular hypertension / glaucoma |
| 05/15/2013 | EP2592143A1 Methods of purifying a nucleic acid and formulation and kit for use in performing such methods |
| 05/15/2013 | EP2592142A1 Organism data processing method and device, storage medium and program |
| 05/15/2013 | EP2592141A2 Method for production of tumor cells from normal mammary epithelial cells |
| 05/15/2013 | EP2592138A2 Mutant microorganism having a hydrocarbon-generating ability and method for producing hydrocarbon using same |
| 05/15/2013 | EP2591793A2 Treatment of autoimmune disease |
| 05/15/2013 | EP2591787A1 Combination motif immune stimulatory oligonucleotides with improved activity |
| 05/15/2013 | EP2591770A2 Compositions for siRNA delivery and methods of manufacturing and using same |
| 05/15/2013 | EP2591126A2 Gene signatures for cancer prognosis |
| 05/15/2013 | EP2591121A1 Production cell line |
| 05/15/2013 | EP2591120A1 Process for producing sulfur-containing -amino acid compound |
| 05/15/2013 | EP2591117A1 Delivery of self-replicating rna using biodegradable polymer particles |
| 05/15/2013 | EP2591116A2 Linear dna molecule delivery using pegylated quantum dots for stable transformation in plants |
| 05/15/2013 | EP2591115A2 Production of functionalized linear dna cassette and quantum dot/nanoparticle mediated delivery in plants |
| 05/15/2013 | EP2591114A2 Immunisation of large mammals with low doses of rna |
| 05/15/2013 | EP2591113A2 Dna element having the activity of enhancing foreign gene expression |
| 05/15/2013 | EP2591112A1 Transgenic plants having altered dahp synthase activity |
| 05/15/2013 | EP2591111A2 Preformed defense in plants |
| 05/15/2013 | EP2591110A1 Control of coleopteran insect pests |
| 05/15/2013 | EP2591109A1 Bacterial surface display and screening of thioether-bridge-containing peptides |
| 05/15/2013 | EP2591107A2 Nucleic acid aptamer-based diagnostic methods with novel techniques for signal enhancement |
| 05/15/2013 | EP2591106A1 Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
| 05/15/2013 | EP2591105A2 Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna |
| 05/15/2013 | EP2591104A2 Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna |
| 05/15/2013 | EP2591103A1 Delivery of rna to different cell types |
| 05/15/2013 | EP2591102A1 Procedure for the specific isolation of total dna content of bacterial germs and a kit for this purpose |
| 05/15/2013 | EP2591101A1 Systems for factor viii processing and methods thereof |
| 05/15/2013 | EP2591095A2 Direct reprogramming of cells to cardiac myocyte fate |
| 05/15/2013 | EP2591093A2 Endothelial cell production by programming |
| 05/15/2013 | EP2590996A2 Glucosinolate transporter protein and uses thereof |
| 05/15/2013 | EP2590995A1 A plant heat-resistance gene jaz5a and use thereof |
| 05/15/2013 | EP2590626A1 Liposomes with lipids having an advantageous pka- value for rna delivery |
| 05/15/2013 | EP2590503A1 A transgenic animal as a model for identifying adult stem cells, and uses thereof |
| 05/15/2013 | EP2590498A2 Improved agronomic traits via genetically induced elevation of phytohormone levels in plants |
| 05/15/2013 | EP2487246A9 Transgenic plants with increased stress tolerance and yield |
| 05/15/2013 | EP2018426B1 Rnai-mediated inhibition of tumor necrosis factor alpha-related conditions |
| 05/15/2013 | CN1665528B Adjuvant viral particle |
| 05/15/2013 | CN103108955A Nucleic acid construct for increasing abiotic stress tolerance in plants |
| 05/15/2013 | CN103108954A Regulation of inducible promoters |
| 05/15/2013 | CN103108953A Method of detecting rhabdomyosarcoma using sample derived from body fluid |